Similar to the reported genetic alterations in sporadic tumors some of these frameshift mutations presumably target genes involved in tumor development, particularly genes with tumor-suppressor function including TGFBR2, BAX (65, 66), CRTC1, BCL9, JAK1, and PTCH1 (67). This evidence concerns the gene JAK1 and neoplasm.